DC Chemicals

DC60478 · Updated 27 October 2026

ALC-0366

Instructions for Use

Before use

Check the supplied lot number, batch COA, approved SDS, quantity and retest date. Pure form: −20 °C, 1 year; In solvent: −80 °C, 6 months; −20 °C, 1 month. Sealed and protected from light.

For small quantities of viscous or oily lipid, volumetric transfer can reduce weighing losses. Confirm solvent compatibility and solubility before preparing a stock; calculated volumes do not establish solubility.

Stock-solution planning

Volume (mL) = mass (mg) × 1000 / [molecular weight × concentration (mM)].

Mass10 mM20 mM
10 mg1.3808 mL0.6904 mL
25 mg3.4521 mL1.7260 mL
50 mg6.9042 mL3.4521 mL
100 mg13.8083 mL6.9042 mL

Literature formulation reference

ComponentDC Chemicals productMolecular weightReported mg/mLCalculated mass %
ALC-0366DC60478724.210.6454.90%
ALC-0159DC52020Not established1.356.97%
DSPCDC57005790.152.4312.54%
CholesterolDCD-041386.654.9625.59%

Table 2 reports mass concentrations, not molar percentages. RNA drug substance is 1.0 mg/mL. Calculated total lipid is 19.38 mg/mL, giving total lipid:RNA 19.38:1 by mass. An exact ALC-0159 molecular-weight convention is not supplied, so an exact molar conversion is not asserted.

Read the complete study conditions, biological results, tolerability and figures →

References

  1. BioNTech SE. US20250009780A1: Agents encoding CLDN6 and CD3 binding elements for treating CLDN6-positive cancers. Published January 9, 2025. Examples 1–2; Tables 2 and 4; Figures 11–12.